Loading clinical trials...
Loading clinical trials...
A Three Year, Prospective, Open-label, Study To Evaluate Clinical Efficacy, Safety And Tolerability Of Atorvastatin In Children And Adolescents With Heterozygous Familial Hypercholesterolemia
Conditions
Interventions
atorvastatin
Locations
40
United States
Phoenix Children's Hospital
Phoenix, Arizona, United States
Children's National Medical Center
Washington D.C., District of Columbia, United States
University of Florida
Gainesville, Florida, United States
Johns Hopkins University
Baltimore, Maryland, United States
Johns Hopkins
Baltimore, Maryland, United States
MEDPACE Clinical Pharmacology Unit
Cincinnati, Ohio, United States
Start Date
March 1, 2009
Primary Completion Date
October 1, 2013
Completion Date
October 1, 2013
Last Updated
February 21, 2021
NCT07058077
NCT01109368
NCT06568471
NCT06461702
NCT02009345
NCT05284513
Lead Sponsor
Pfizer's Upjohn has merged with Mylan to form Viatris Inc.
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions